Finally, we discuss the promise of new therapies that address the underlying biology of bone aging, most notably through removal of senescent cells or modulating mTOR pathways, to improve bone health across the human life course and especially in people living with diabetes. The gene discussed is MTOR; the disease is diabetes mellitus.